Abstract:Schizophrenia is a complex mental disorder whose course varies with periods of deterioration and symptomatic improvement without diagnosis and treatment specific for the disease. So far, it has not been possible to clearly define what kinds of functional and structural changes are responsible for the onset or recurrence of acute psychotic decompensation in the course of schizophrenia, and to what extent personality disorders may precede the appearance of the appropriate symptoms. The work combines magnetic resonance spectroscopy imaging with clinical evaluation and laboratory tests to determine the likely pathway of schizophrenia development by identifying peripheral cerebral biomarkers compared to personality disorders. The relationship between the level of metabolites in the brain, the clinical status of patients according to International Statistical Classification of Diseases and Related Health Problems, 10th Revision ICD-10, duration of untreated psychosis (DUP), and biochemical indices related to redox balance (malondialdehyde), the efficiency of antioxidant systems (FRAP), and bioenergetic metabolism of mitochondria, were investigated. There was a reduction in the level of brain N-acetyl-aspartate and glutamate in the anterior cingulate gyrus of patients with schisophrenia compared to the other groups that seems more to reflect a biological etiopathological factor of psychosis. Decreased activity of brain metabolites correlated with increased peripheral oxidative stress (increased malondialdehyde MDA) associated with decreased efficiency of antioxidant systems (FRAP) and the breakdown of clinical symptoms in patients with schizophrenia in the course of psychotic decompensation compared to other groups. The period of untreated psychosis correlated negatively with glucose value in the brain of people with schizophrenia, and positively with choline level. The demonstrated differences between two psychiatric units, such as schizophrenia and personality disorders in relation to healthy people, may be used to improve the diagnosis and prognosis of schizophrenia compared to other heterogenous psychopathology in the future. The collapse of clinical symptoms of patients with schizophrenia in the course of psychotic decompensation may be associated with the occurrence of specific schizotypes, the determination of which is possible by determining common relationships between changes in metabolic activity of particular brain structures and peripheral parameters, which may be an important biological etiopathological factor of psychosis. Markers of peripheral redox imbalance associated with disturbed bioenergy metabolism in the brain may provide specific biological factors of psychosis however, they need to be confirmed in further studies.

Abnormalities in the absolute power of Delta and Alpha rhythms in the frontal lobe of patients suffering from psychosomatic disorders

Relationship between anhedonia, biological rhythms, functioning and depression severity in patients with bipolar disorder.

Is there a relationship between resting state connectivity within large-scale functional networks and implicit motor learning impairments in schizophrenia and bipolar disorder?

Abnormal Dynamics of EEG Oscillations in Schizophrenia Patients on Multiple Time Scales

Mapping the Human Brain in Frequency Band Analysis of Brain Cortex Electroencephalographic Activity for Selected Psychiatric Disorders

Abnormal Oscillations in Beta and Gamma of Generalized Anxiety Disorder Patients Based on Resting State EEG.

A Study of Biological Rhythm Disturbances in Polish Remitted Bipolar Patients using the BRIAN, CSM, and SWPAQ Scales

Assessment of symptom severity in psychotic disorder patients based on heart rate variability and accelerometer mobility data

Abnormal EEG Complexity in Patients with Schizophrenia and Depression

Psychopathological symptoms in fibromyalgia and their associations with resistance to pharmacotherapy with SNRI

The MEG and clinical features of bipolar depression

Beyond alpha power: EEG spatial and spectral gradients robustly stratify disorders of consciousness

The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders

Alpha Wavelet Power as a Biomarker of Antidepressant Treatment Response in Bipolar Depression

Abnormal Alpha Rhythm During Self-Referential Processing in Schizophrenia Patients

Schizotypy, affective temperaments and anhedonia in bipolar depression

Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. IV. Brain dysfunction during motor activation measured by EEG mapping

Exploring Sleep Architecture in Polish Patients with Multiple Sclerosis: A Polysomnography Study

[Determining the risk of maladaptation using an electroencephalogram to prevent mental strain]

Paroxysmal rush of intrusive eidetic images – diagnostic doubts. Case report

Abnormal Entropy Modulation of the EEG Signal in Patients With Schizophrenia During the Auditory Paired-Stimulus Paradigm